Literature DB >> 23920152

Bacterial-binding chitosan microspheres for gastric infection treatment and prevention.

Inês C Gonçalves1, Ana Magalhães, Mariana Fernandes, Inês V Rodrigues, Celso A Reis, M Cristina L Martins.   

Abstract

Helicobacter pylori (H. pylori) colonizes the gastric mucosa of over 50% of the world population, causing several pathologies, such as gastric ulcers and gastric cancer. Since current antibiotic treatments are inefficient in 20% of cases alternative therapies are needed. This work reports the ability of chitosan microspheres to adhere to H. pylori and prevent/remove H. pylori colonization. Adhesion of H. pylori strains with different functional adhesins (BabA and/or SabA) to chitosan microspheres (diameter 167 ± 27 μm) occurs at both pH 2.6 and 6.0, but is higher at pH 6.0. Bacterial adhesion to a gastric cell line expressing sialylated carbohydrates (SabA receptors) was performed at the same pH values using H. pylori strains with and without SabA. At both pH values addition of microspheres to gastric cells before and after pre-incubation with H. pylori decreased bacterial adhesion to cells. Furthermore, the chitosan microspheres were non-cytotoxic. These findings reveal the potential of chitosan microspheres as an alternative or complementary treatment for H. pylori gastric eradication or prevention of H. pylori colonization.
Copyright © 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bacterial adhesion; Biomaterials; Chitosan microspheres; Gastric cancer; Helicobacter pylori

Mesh:

Substances:

Year:  2013        PMID: 23920152     DOI: 10.1016/j.actbio.2013.07.034

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  4 in total

Review 1.  Mucin-Type O-Glycosylation in Gastric Carcinogenesis.

Authors:  Henrique O Duarte; Daniela Freitas; Catarina Gomes; Joana Gomes; Ana Magalhães; Celso A Reis
Journal:  Biomolecules       Date:  2016-07-11

Review 2.  Biomaterials for Helicobacter pylori therapy: therapeutic potential and future perspectives.

Authors:  Yongkang Lai; Wei Wei; Yiqi Du; Jie Gao; Zhaoshen Li
Journal:  Gut Microbes       Date:  2022 Jan-Dec

3.  Surface Grafted MSI-78A Antimicrobial Peptide has High Potential for Gastric Infection Management.

Authors:  Paula Parreira; Claudia Monteiro; Vanessa Graça; Joana Gomes; Sílvia Maia; Paula Gomes; Inês C Gonçalves; M Cristina L Martins
Journal:  Sci Rep       Date:  2019-12-03       Impact factor: 4.379

4.  Effect of Native Gastric Mucus on in vivo Hybridization Therapies Directed at Helicobacter pylori.

Authors:  Rita S Santos; George R Dakwar; Ranhua Xiong; Katrien Forier; Katrien Remaut; Stephan Stremersch; Nuno Guimarães; Sílvia Fontenete; Jesper Wengel; Marina Leite; Céu Figueiredo; Stefaan C De Smedt; Kevin Braeckmans; Nuno F Azevedo
Journal:  Mol Ther Nucleic Acids       Date:  2015-12-08       Impact factor: 10.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.